Insight

4-Chloro-3-Nitrobenzenesulfonamide Bulk Price 2026 Trends

  • Market Outlook: Bulk pricing is stabilizing due to optimized chlorosulphonation processes and raw material availability.
  • Purity Standards: Industrial grade requires >99.0% HPLC purity with strict control on heavy metals and residual solvents.
  • Procurement Strategy: Long-term contracts with verified global manufacturers mitigate volatility in the pharmaceutical intermediate sector.

The demand for Benzenesulfonamide 4-chloro-3-nitro (CAS: 97-09-6) continues to rise within the fine chemical and pharmaceutical sectors. As a critical building block for azo dyes and specialized medicinal compounds, understanding the cost drivers and synthesis efficiencies is paramount for procurement managers. This analysis examines the technical specifications, manufacturing processes, and projected bulk price trends leading into 2026.

Global Market Analysis for 4-Chloro-3-nitrobenzenesulfonamide Bulk Price

The global supply chain for sulfonamide derivatives has matured, shifting focus from small-scale laboratory reagents to large-scale industrial purity production. Historically, price fluctuations were driven by the cost of key raw materials, specifically 2-chloronitrobenzene and chlorosulphonic acid. However, recent optimizations in the synthesis route have allowed leading facilities to maintain consistent output despite minor raw material volatility.

For buyers evaluating the bulk price, it is essential to distinguish between reagent-grade material sold in gram quantities and industrial-grade stock intended for multi-kilogram synthesis. Laboratory suppliers often charge a premium for small packaging, with prices ranging significantly per gram. In contrast, bulk procurement leverages economies of scale, reducing the cost per kilogram substantially. A reliable global manufacturer will offer tiered pricing structures that reflect volume commitments, ensuring cost-efficiency for large-scale production runs.

Volume-Based Pricing Tiers for Pharmaceutical Intermediates

As a high-value pharmaceutical intermediate, 4-Chloro-3-nitrobenzenesulfonamide exhibits distinct pricing tiers based on quantity and purity specifications. The following table outlines estimated market pricing structures based on current industrial data, excluding retail markups associated with small-pack distributors.

Package Size Estimated Unit Price (USD) Purity Specification Typical Application
5g - 25g (Lab Scale) $25.00 - $85.00 95% - 98% R&D, Analytical Standards
100g - 1kg (Pilot Scale) $150.00 - $400.00 98% - 99% Process Development
5kg - 25kg (Bulk) Request Quote >99.0% (HPLC) Commercial Manufacturing
100kg+ (Industrial) Contract Pricing >99.0% + Custom COA Large Scale Production

Procurement teams should note that prices for smaller quantities often include significant logistical and packaging overheads. For commercial synthesis, securing a contract for industrial volumes is the only viable method to maintain margin integrity. When sourcing high-purity 4-Chloro-3-nitrobenzenesulfonamide, buyers should prioritize suppliers who can provide comprehensive Certificates of Analysis (COA) detailing impurity profiles, including residual solvents and heavy metals.

Technical Synthesis and Quality Control

The manufacturing process typically involves the chlorosulphonation of 2-chloronitrobenzene followed by amidation. In a standard industrial process, chlorosulphonic acid is added slowly to the substrate, maintaining a reaction temperature around 100°C for approximately 6 hours. The reaction mass is then quenched into chilled aqueous ammonia. Critical control points include the temperature during the ammonia addition phase, which must be kept low (around -10°C initially) to prevent side reactions and ensure high yield.

Post-reaction processing involves filtration, washing, and recrystallization, often using methanol or toluene systems to achieve the desired crystal form and purity. The final product appears as a white to off-white crystalline powder with a melting point between 25-35°C. Strict adherence to Good Manufacturing Practices (GMP) ensures that the 3-Nitro-4-chlorobenzenesulfonamide produced meets the rigorous standards required for downstream pharmaceutical applications.

2026 Cost Forecast and Procurement Strategy

Looking toward 2026, the cost forecast for this sulfonamide derivative remains stable, provided that supply chains for precursor aromatics remain uninterrupted. Energy costs and environmental compliance regulations in manufacturing hubs are the primary variables that could influence pricing. Buyers are advised to establish long-term agreements with established entities such as NINGBO INNO PHARMCHEM CO.,LTD. to lock in favorable rates and ensure a stable supply.

Strategic procurement should focus on vendors capable of custom synthesis and scale-up flexibility. The ability to adjust production schedules based on demand fluctuations is a key value driver. Furthermore, verifying the supplier's capacity to handle hazardous substances safely, in compliance with TSCA and REACH regulations, is non-negotiable. By partnering with a top-tier manufacturer, organizations can mitigate the risk of supply disruptions and maintain consistent quality across batches.

In conclusion, while spot prices for laboratory quantities may vary, the bulk market for 4-Chloro-3-nitrobenzenesulfonamide is poised for stability. Prioritizing industrial purity, verifying synthesis routes, and securing partnerships with reputable manufacturers like NINGBO INNO PHARMCHEM CO.,LTD. will be the defining factors for successful procurement strategies in the coming years.